What is Oscor?
Founded in 1982 and headquartered in Palm Harbor, Florida, Oscor has established itself as a critical manufacturer and marketer of specialized medical devices. The company maintains a robust portfolio centered on cardiac pacemaker components and advanced catheter systems. By providing essential hardware to the global medical community, Oscor occupies a vital niche in the cardiovascular health sector. Its long-standing operational history serves as a testament to its ability to adapt to evolving regulatory standards and clinical requirements, positioning the firm as a reliable partner for healthcare providers worldwide.
How much funding has Oscor raised?
Oscor has raised a total of $147M across 2 funding rounds:
Unspecified
$145M
Debt
$2M
Unspecified (2015): $145M, investors not publicly disclosed
Debt (2020): $2M led by PPP
Key Investors in Oscor
PPP
Public-Private Partnership
Undisclosed Investor
An undisclosed investor participating in the funding round, focusing on long-term value creation within the medical device manufacturing sector.
What's next for Oscor?
With the recent infusion of capital, Oscor is well-positioned to accelerate its strategic initiatives, particularly in the refinement of its cardiac and catheter product lines. The company is expected to leverage this financial backing to enhance its manufacturing capabilities and expand its international distribution footprint. As the medical device industry faces increasing pressure for high-precision, reliable equipment, Oscor's focus on core competencies will likely drive sustained growth. Future developments will likely center on integrating next-generation materials into their existing product architecture, ensuring that the firm remains at the forefront of cardiac care technology while optimizing its enterprise-level supply chain efficiency.
See full Oscor company page
